DCC-3116

DCC-3116
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay45313-1 1 mg -

6 - 10 business days*

55.00€
Cay45313-5 5 mg -

6 - 10 business days*

258.00€
Cay45313-10 10 mg -

6 - 10 business days*

408.00€
Cay45313-50 50 mg -

6 - 10 business days*

949.00€
 
An inhibitor of ULK1/2, decreases ATG13 phosphorylation in K-RasG12C-expressing NCI H2122,... more
Product information "DCC-3116"
An inhibitor of ULK1/2, decreases ATG13 phosphorylation in K-RasG12C-expressing NCI H2122, Calu-1, and NCI H358 cells at 2 µM, reduces basal autophagy and sotorasib-induced autophagy in NCI H2122, Calu-1, and NCI H358 cells, inhibits the proliferation of Calu-1 and NCI H358 cells at 2 µM, with a synergistic effect with sotorasib in NCI H2122 and Calu-1 cells, cooperatively increases sotorasib-induced reductions in tumor volume in NCI H2122 and Calu-1 mouse xenograft models. SMILES: CN1CCN(C2=CC=C(NC(N=C3NCCCN4CCOCCC4=O)=NC=C3C(F)(F)F)C(CC)=C2)CC1. InChi Code: InChI=1S/C26H36F3N7O2/c1-3-19-17-20(35-12-10-34(2)11-13-35)5-6-22(19)32-25-31-18-21(26(27,28)29)24(33-25)30-8-4-9-36-14-16-38-15-7-23(36)37/h5-6,17-18H,3-4,7-16H2,1-2H3,(H2,30,31,32,33). InChi Key: CNBTYICEJGEABG-UHFFFAOYSA-N
Keywords: Inlexisertib, 4-[3-[[2-[[2-ethyl-4-(4-methyl-1-piperazinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]propyl]tetrahydro-1,4-oxazepin-5(2H)-one
Supplier: Cayman Chemical
Supplier-Nr: 45313

Properties

Application: ULK1/2 inhibitor
MW: 535.62 D
Formula: C26H36F3N7O2
Purity: >98%
Format: Solid

Database Information

CAS : 2543673-19-2| Matching products
KEGG ID : K21357 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "DCC-3116"
Write a review
or to review a product.
Viewed